Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
J Clin Dent ; 6 Spec No: 46-53, 1995.
Article in English | MEDLINE | ID: mdl-8593193

ABSTRACT

The effects of stabilized 0.454% stannous fluoride dentifrices on supragingival plaque, gingival inflammation and gingival bleeding were studied in 549 adult male and female subjects who completed a six-month, double blind clinical study. Following an oral prophylaxis, subjects were randomly assigned to brush with one of the following dentifrices: 1) 0.454% SnF2 stabilized with 2.08% sodium gluconate, 2) 0.454% SnF2 stabilized with 4.16% sodium gluconate, 3) an experimental dentifrice, or 4) 0.243% NaF control dentifrice. Follow-up examinations were conducted at 3 and 6 months. Compared to the control dentifrice at 6 months, stannous fluoride dentifrices stabilized with 2.08% or 4.16% sodium gluconate significantly reduced gingivitis by 18.8% and 18.0%, respectively. There were no statistically significant differences between the two stabilized SnF2 groups with respect to their beneficial effects on gingival health. Gingival bleeding was also reduced, relative to the control dentifrice, for both stabilized SnF2 dentifrices. However, these differences were not statistically significant at p=0.05. The stabilized SnF2 dentifrices were not significantly different from the control dentifrice in their effects on supragingival plaque. No significant differences in adverse oral soft tissue effects were observed between the test and control groups. As expected, accumulation of extrinsic tooth stain increased in the stabilized SnF2 groups. However, the difficulty in removing accumulated dental stain was similar between the control and stabilized SnF2 dentifrices. Since use of SnF2 dentifrices has been reported to produce tooth stain, gingivitis examinations were done with and without custom-made tooth covers to evaluate the potential for examiner bias. Comparable gingivitis and gingival bleeding benefits were observed when the evaluations were conducted with or without the tooth covers. Results from this study support that 0.454% stabilized stannous fluoride dentifrices can provide an important adjunct to the prevention and control of gingivitis when used in combination with regular personal oral hygiene procedures and professional care.


Subject(s)
Dental Plaque/prevention & control , Dentifrices/therapeutic use , Gingivitis/prevention & control , Tin Fluorides/therapeutic use , Adult , Analysis of Variance , Dental Plaque Index , Dental Prophylaxis , Dentifrices/chemistry , Double-Blind Method , Drug Stability , Female , Follow-Up Studies , Gingival Hemorrhage/prevention & control , Gluconates/analysis , Humans , Male , Middle Aged , Periodontal Index , Statistics, Nonparametric , Tin Fluorides/adverse effects , Tooth Discoloration/chemically induced , Tooth Discoloration/therapy
2.
Membr Biochem ; 6(4): 269-89, 1986.
Article in English | MEDLINE | ID: mdl-3574139

ABSTRACT

Intrinsic tryptophan fluorescence in red cell ghost membranes labeled with N-ethylmaleimide (N-EM) is quenched in a dose-dependent manner by the organic mercurial p-chloromercuribenzene sulfonate (p-CMBS). Fluorescence lifetime analysis shows that quenching occurs by a static mechanism. Binding of p-CMBS occurs by a rapid (less than 5 s) biomolecular association (dissociation constant K1 = 1.8 mM) followed by a slower unimolecular transition with forward rate constant k2 = 0.015 s-1 and reverse rate constant k-2 = 0.0054 s-1. Analysis of the temperature dependence of k2 gives delta H = 6.5 kcal/mol and delta S = -21 eu. The mercurial compounds p-chloromercuribenzoic acid, p-aminophenylmercuric acetate, and mercuric chloride quench red cell tryptophan fluorescence by the same mechanism as p-CMBS does; the measured k2 value was the same for each compound, whereas K1 varied. p-CMBS also quenches the tryptophan fluorescence in vesicles reconstituted with purified band 3, the red cell anion exchange protein, in a manner similar to that in ghost membranes. These experiments define a mercurial binding site on band 3 in ghosts treated with N-EM and establish the binding mechanism to this site. The characteristics of this p-CMBS binding site on band 3 differ significantly from those of the p-CMBS binding site involved in red cell water and urea transport inhibition.


Subject(s)
Chloromercuribenzoates/pharmacology , Erythrocyte Membrane/drug effects , Anion Exchange Protein 1, Erythrocyte/metabolism , Biological Transport/drug effects , Body Water/metabolism , Chloromercuribenzoates/metabolism , Depression, Chemical , Dose-Response Relationship, Drug , Erythrocyte Membrane/metabolism , Ethylmaleimide , Fluorescence , Humans , Kinetics , Phenylmercuric Acetate/analogs & derivatives , Phenylmercuric Acetate/metabolism , Phenylmercuric Acetate/pharmacology , Protein Binding , Tryptophan , Urea/metabolism , p-Chloromercuribenzoic Acid
3.
Biochim Biophys Acta ; 818(2): 158-70, 1985 Aug 27.
Article in English | MEDLINE | ID: mdl-2992587

ABSTRACT

Inhibition of red cell water transport by the sulfhydryl reagent 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) has been reported by Naccache and Sha'afi ((1974) J. Cell Physiol. 84, 449-456) but other investigators have not been able to confirm this observation. Brown et al. ((1975) Nature 254, 523-525) have shown that, under appropriate conditions, DTNB binds only to band 3 in the red cell membrane. We have made a detailed investigation of DTNB binding to red cell membranes that had been treated with the sulfhydryl reagent N-ethylmaleimide (NEM), and our results confirm the observation of Brown et al. Since this covalent binding site does not react with either N-ethylmaleimide or the sulfhydryl reagent pCMBS (p-chloromercuribenzenesulfonate), its presence has not previously been reported. This covalent site does not inhibit water transport nor does it affect any transport process we have studied. There is an additional low-affinity (non-covalent) DTNB site that Reithmeier ((1983) Biochim. Biophys. Acta 732, 122-125) has shown to inhibit anion transport. In N-ethylmaleimide-treated red cells, we have found that this binding site inhibits water transport and that the inhibition can be partially reversed by the specific stilbene anion exchange transport inhibitor 4,4'-diisothiocyanostilbene-2,2'-disulfonate (DIDS), thus linking water transport to anion exchange. DTNB binding to this low-affinity site also inhibits ethylene glycol and methyl urea transport with the same KI as that for water inhibition, thus linking these transport systems to that for water and anions. These results support the view that band 3 is a principal constituent of the red cell aqueous channel, through which urea and ethylene glycol also enter the cell.


Subject(s)
Anion Exchange Protein 1, Erythrocyte/metabolism , Dithionitrobenzoic Acid/blood , Erythrocyte Membrane/metabolism , Nitrobenzoates/blood , 4-Chloromercuribenzenesulfonate/pharmacology , Binding Sites , Biological Transport , Cell Membrane Permeability/drug effects , Dithionitrobenzoic Acid/pharmacology , Ethylene Glycols/blood , Ethylmaleimide , Humans , Kinetics , Methylurea Compounds/blood , Osmosis , Protein Binding , Spectrometry, Fluorescence , Sulfhydryl Compounds/blood , Water/metabolism
4.
Biochemistry ; 24(8): 1883-90, 1985 Apr 09.
Article in English | MEDLINE | ID: mdl-4016089

ABSTRACT

Resonance energy transfer was used to study the structure of cytochrome b5 and its nonpolar segment reconstituted into sonicated vesicles of dimyristoylphosphatidylcholine. The n-(9-anthroyloxy) (AO) fatty acid probes were added to these vesicles, and energy-transfer measurements were carried out between tryptophan and AO, tryptophan and the heme moiety of cytochrome b5, and AO and heme. Results of these measurements were analyzed by using the methods outlined in the previous paper [Kleinfeld, A. M. (1985) Biochemistry (preceding paper in this issue)]. We find, in agreement with Fleming et al. [Fleming, P. J., Koppel, D. E., Lau, A. L. Y., & Strittmatter, P. (1979) Biochemistry 18, 5458-5464], that the fluorescent tryptophan in both forms of the protein is buried about 20 A from the surface and that most of the fluorescence is associated with a single tryptophan. The results are consistent with the AO probe distance of closest approach to the protein, greater for whole b5 than for the nonpolar peptide. The tryptophan-heme and AO-heme measurements indicate that the heme moiety is about 15 A from the surface of the membrane. The agreement of our results with the previous studies supports the description of tryptophan-AO energy transfer outlined in the preceding paper.


Subject(s)
Cytochrome b Group/analysis , Membrane Proteins/analysis , Animals , Cytochromes b5 , Energy Transfer , Fluorescent Dyes , Heme , Liver , Protein Binding , Rabbits , Spectrometry, Fluorescence , Spectrophotometry , Stearic Acids , Structure-Activity Relationship , Tryptophan/analysis
5.
Biochim Biophys Acta ; 778(2): 253-9, 1984 Dec 05.
Article in English | MEDLINE | ID: mdl-6093883

ABSTRACT

The human red cell anion transport protein, band 3, contains six pCMBS (p-chloromercuribenzene sulfonate) reactive SH groups, five of which react with N-ethylmaleimide. We have carried out equilibrium binding experiments using N-ethylmaleimide-treated red cell ghosts and found that the sulfhydryl reactive water transport inhibitor, pCMBS, inhibits the binding to band 3 of the specific anion exchange inhibitor DBDS (4,4'-dibenzoamido-2,2'-disulfonic stilbene) in a non-competitive manner. Stopped-flow kinetic studies, in which DBDS is mixed with ghosts in the presence of pCMBS, show that pCMBS slows the DBDS induced conformational change in band 3. A non-competitive reaction scheme has been developed which incorporates the quantitative results of equilibrium and kinetic studies. The pCMBS effect on DBDS binding and kinetics is reversed with 5 mM cysteine suggesting a sulfhydryl bond is involved in pCMBS binding to band 3. These data suggest that pCMBS has a specific binding site on band 3, consistent with the hypothesis that band 3 mediates red cell water transport.


Subject(s)
4-Chloromercuribenzenesulfonate/pharmacology , Anion Exchange Protein 1, Erythrocyte/metabolism , Body Water/metabolism , Erythrocyte Membrane/metabolism , Phenylmercury Compounds/pharmacology , 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid/analogs & derivatives , 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid/pharmacology , Binding Sites , Ethylmaleimide/pharmacology , Humans , Mathematics , Time Factors
6.
Biochim Biophys Acta ; 778(1): 185-90, 1984 Nov 21.
Article in English | MEDLINE | ID: mdl-6093879

ABSTRACT

The organomercurial reagent p-chloromercuribenzene sulfonate (PCMBS) is an inhibitor of osmotic water permeability in the human red cell membrane. We have found that thiourea, when added along with PCMBS to a red cell suspension, interferes with this inhibition and at high enough concentrations prevents the inhibition from developing altogether. For a 2 mM PCMBS concentration Ki = 3 +/- 1 mM. When thiourea is added at a later time, the PCMBS inhibition, which normally takes about 20 min to develop fully, is halted and remains fixed at the value attained by that time. Thiourea also inhibits the reversal of PCMBS inhibition by a 10 mM concentration of cysteine, the half-time for reversal increasing by more than an order of magnitude when [thiourea] = 50 mM. Possible implications for the nature of the water and urea transport pathways across the red cell membrane are discussed.


Subject(s)
4-Chloromercuribenzenesulfonate/pharmacology , Erythrocyte Membrane/metabolism , Phenylmercury Compounds/pharmacology , Thiourea/pharmacology , Water/metabolism , Anion Exchange Protein 1, Erythrocyte/metabolism , Biological Transport/drug effects , Cysteine/pharmacology , Drug Interactions , Humans , Kinetics , Osmosis/drug effects , Sulfhydryl Compounds/blood
7.
Biochim Biophys Acta ; 772(3): 313-20, 1984 May 30.
Article in English | MEDLINE | ID: mdl-6326827

ABSTRACT

It has been suggested that the human red cell anion transport protein, band 3, is the site not only of the cation leak induced in human red cells by treatment with the sulfhydryl reagent pCMBS (p-chloromercuribenzene sulfonate) but is also the site for the inhibition of water flux induced by the same reagent. Our experiments indicate that N-ethylmaleimide, a sulfhydryl reagent that does not inhibit water transport, also does not induce a cation leak. We have found that the profile of inhibition of water transport by mercurial sulfhydryl reagents is closely mirrored by the effect of these same reagents on the induction of the cation leak. In order to determine whether these effects are caused by band 3 we have reconstituted phosphatidylcholine vesicles containing only purified band 3. Control experiments indicate that these band 3 vesicles do not contain (Na+ + K+)-ATPase as measured by ATP dephosphorylation. pCMBS treatment caused a significant increase in the cation leak in this preparation, consistent with the view that the pCMBS-induced cation leak in whole red cells is mediated by band 3.


Subject(s)
Anion Exchange Protein 1, Erythrocyte/metabolism , Cell Membrane Permeability/drug effects , Erythrocyte Membrane/drug effects , Sulfhydryl Reagents/pharmacology , Cations , Chloromercuribenzoates/pharmacology , Ethylmaleimide/pharmacology , Humans , Ion Channels/drug effects , Phenylmercuric Acetate/analogs & derivatives , Phenylmercuric Acetate/pharmacology , Water/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...